Hesperidin lessens rotenone induced Parkinson diseases angiogenesis in nigrostriatal neuronal death through the AMPK/FOXO3 Signaling pathway
Objective: This study is to investigate the neuroprotective effect of HSP in a mouse model of Parkinson's disease (PD) caused by rotenone, with an emphasis…Spray with Nasal Mucoadhesive Microspheres for Treating Parkinsonism.
Objective: Although levodopa is the preferred medication for treating Parkinson's disease, it has a very poor brain absorption and limited oral bioavailability. The goal of…Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure
Objective: To determine whether Dopamine transporter imaging impacts diagnosis in parkinsonian patients Background: Dopamine transporter imaging (DaTscan) is a diagnostic tool used to assess loss…Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.
Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…Parkinson’s disease in a Special Population -Diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists-
Objective: We studied diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists for a long time. Background: Schizophrenia…Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?
Objective: To perform a meta-analysis to show the association between different Antiepileptic Drugs(AEDs) and Parkinson’s disease(PD). Background: PD is a neurodegenerative disorder affecting 1-2% of…Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol
Objective: To reproduce the side effects of antipsychotic drugs (drug-induced Parkinsonism and tardive dyskinesia) in rats and elucidate its pathomechanism by examining morphological changes in…Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model
Objective: This research aims to assess whether Ibudilast (IBD), a phosphodiesterase IV (PDE IV) inhibitor, can mitigate the damage induced by 3-nitropropionic acid (3-NP) in…Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model
Objective: This study aimed to evaluate the neuroprotective and antiparkinsonian effects of the ethanolic extract of Amorphophallus paeoniifolius tuber (APT) against haloperidol-induced Parkinson’s Disease (PD)…Can optical coherence tomography differentiate Parkinson’s disease from drug-induced parkinsonism?
Objective: We aimed to determine whether optical coherence tomography (OCT) findings could differentiate DIP from Parkinson’s disease (PD). Background: Drug-induced parkinsonism (DIP) is common, but…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »